Overall, TRAF7 alteration activates both tumor supportive (CDC42) and tumor suppressive (KLF4) pathways, and the co-occurrence of TRAF7 and KLF4 mutations allows for hyperactivation of Ras signaling as well as impaired tumor suppression, leading to meningioma growth. Here, KLF4 is linked to meningioma.